Subhankar Biswas

931 total citations
22 papers, 713 citations indexed

About

Subhankar Biswas is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Subhankar Biswas has authored 22 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Subhankar Biswas's work include Histone Deacetylase Inhibitors Research (4 papers), Synthesis and biological activity (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Subhankar Biswas is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Synthesis and biological activity (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Subhankar Biswas collaborates with scholars based in India, Malaysia and Singapore. Subhankar Biswas's co-authors include C. Mallikarjuna Rao, N.D. Reddy, Nitesh Kumar, Krishnadas Nandakumar, Pawan G. Nayak, B. S. Jayashree, Karthik Gourishetti, Sri Pragnya Cheruku, Madhavan Nampoothiri and Richard Lobo and has published in prestigious journals such as Scientific Reports, Pharmacology & Therapeutics and Journal of Ethnopharmacology.

In The Last Decade

Subhankar Biswas

22 papers receiving 702 citations

Peers

Countries citing papers authored by Subhankar Biswas

Since Specialization

Citations

This map shows the geographic impact of Subhankar Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhankar Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhankar Biswas more than expected).

Fields of papers citing papers by Subhankar Biswas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhankar Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhankar Biswas. The network helps show where Subhankar Biswas may publish in the future.

Co-authorship network of co-authors of Subhankar Biswas

This figure shows the co-authorship network connecting the top 25 collaborators of Subhankar Biswas. A scholar is included among the top collaborators of Subhankar Biswas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhankar Biswas. Subhankar Biswas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent Developments in Intermolecular Cross‐Rauhut‐Currier Reactions 2023 ·The Chemical Record ·Subhankar Biswas, (unknown), Subhas Chandra Pan	11
2	An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid 2022 ·Scientific Reports ·(unknown), (unknown), Subhankar Biswas, (unknown), Gautam Sethi, Sudha Warrier	2
3	Evaluation of Hepatoprotective Effect of a Polyherbal Megakutki against Paracetamol-Induced Hepatotoxicity 2020 ·Indian Journal of Pharmaceutical Education and Research ·(unknown), (unknown), Sandeep K. Singhal, Karthik Gourishetti, Subhankar Biswas, Krishnadas Nandakumar, (unknown), (unknown), (unknown), Suhani Sumalatha, Nitesh Kumar	1
4	Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy 2018 ·European Journal of Pharmacology ·Subhankar Biswas, C. Mallikarjuna Rao	273
5	Evaluation of Novel 3-Hydroxyflavone Analogues as HDAC Inhibitors against Colorectal Cancer 2018 ·Advances in Pharmacological Sciences ·Subhankar Biswas, N.D. Reddy, B. S. Jayashree, C. Mallikarjuna Rao	19
6	Pinocembrin-Enriched Fractions of Elytranthe parasitica (L.) Danser Modulates Apoptotic and MAPK Cellular Signaling in HepG2 Cells 2018 ·Anti-Cancer Agents in Medicinal Chemistry ·(unknown), (unknown), Sanchari Basu Mallik, Subhankar Biswas, Jesil Mathew Aranjani, Krishnadas Nandakumar, (unknown), Richard Lobo	8
7	Combined Administration of Monosodium Glutamate and High Sucrose Diet Accelerates the Induction of Type 2 Diabetes, Vascular Dysfunction, and Memory Impairment in Rats 2018 ·Journal of Environmental Pathology Toxicology and Oncology ·(unknown), (unknown), (unknown), Subhankar Biswas, Pawan G. Nayak, Jayesh Mudgal, Anoop Kishore, Krishnadas Nandakumar	12
8	Epigenetics in cancer: Fundamentals and Beyond 2017 ·Pharmacology & Therapeutics ·Subhankar Biswas, C. Mallikarjuna Rao	180
9	Pinocembrin enriched fraction of Elytranthe parasitica (L.) Danser induces apoptosis in HCT 116 colorectal cancer cells 2017 ·Journal of Infection and Chemotherapy ·(unknown), Subhankar Biswas, (unknown), Sanchari Basu Mallik, (unknown), (unknown), Jesil Mathew Aranjani, Krishnadas Nandakumar, Richard Lobo	17
10	Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats 2017 ·Cytotechnology ·Sri Pragnya Cheruku, (unknown), C. Mallikarjuna Rao, Subhankar Biswas, Krishnadas Nandakumar, Madhavan Nampoothiri, Karthik Gourishetti, Nitesh Kumar	44
11	Evaluation of in vitro and in vivo anticancer potential of two 5-acetamido chalcones against breast cancer 2017 ·PubMed ·(unknown), Nitesh Kumar, (unknown), Subhankar Biswas, Karthik Gourishetti, (unknown), (unknown), C. Mallikarjuna Rao	6
12	In vitro and in vivo anticancer studies of 2ʹ-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest 2017 ·PubMed ·(unknown), Subhankar Biswas, N.D. Reddy, B. S. Jayashree, Nitesh Kumar, C. Mallikarjuna Rao	30
13	Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma 2016 ·BMC Complementary and Alternative Medicine ·(unknown), Subhankar Biswas, (unknown), (unknown), (unknown), Krishnadas Nandakumar, Jesil Mathew Aranjani, Richard Lobo	18
14	Bulbophyllum sterile petroleum ether fraction induces apoptosis in vitro and ameliorates tumor progression in vivo 2016 ·Biomedicine & Pharmacotherapy ·Subhankar Biswas, (unknown), N.D. Reddy, (unknown), Pawan G. Nayak, M. Manjunath Setty, K. Sreedhara Ranganath Pai	9
15	An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells 2016 ·Chemico-Biological Interactions ·N.D. Reddy, (unknown), Subhankar Biswas, Pawan G. Nayak, Nitesh Kumar, C. Mallikarjuna Rao	34
16	In vitro mechanistic and in vivo anti-tumor studies of Glycosmis pentaphylla (Retz.) DC against breast cancer 2016 ·Journal of Ethnopharmacology ·(unknown), N.D. Reddy, Pawan G. Nayak, Subhankar Biswas, K. Srinivasan, C. Mallikarjuna Rao	8
17	Selected novel 5’-amino-2’-hydroxy-1,3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G0/G1 phase 2016 ·PubMed ·(unknown), Kalyani Srinivasan, Nitesh Kumar, N.D. Reddy, Subhankar Biswas, C. Mallikarjuna Rao, Sudheer Moorkoth	5
18	Synthesis and evaluation of anti-cancer activity of some 6-Aminoflavones 2015 ·Scholar Science Journals - International Journal of Biomedical Research ·(unknown), (unknown), (unknown), Nitesh Kumar, N.D. Reddy, Subhankar Biswas, Sudheer Moorkoth	3
19	Assessment of the in vitro cytotoxicity and in vivo anti-tumor activity of the alcoholic stem bark extract/fractions of Mimusops elengi Linn. 2015 ·Cytotechnology ·(unknown), (unknown), Subhankar Biswas, Pawan G. Nayak, Naseer Maliyakkal, M. Manjunath Setty, Karthik Gourishetti, K. Sreedhara Ranganath Pai	14
20	Protective Effects of Aqueous Extract ofSolanum nigrumLinn. Leaves in Rat Models of Oral Mucositis 2014 ·The Scientific World JOURNAL ·(unknown), Subhankar Biswas, (unknown), (unknown), Krishnadas Nandakumar	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact